La Jolla, Calif. and Norwood, Mass. (PRWEB) August 29, 2013
California Healthcare Institute (CHI) announced today a partnership with BioPharm Insight(TM), a comprehensive resource for biopharma pipelines and intelligence. BioPharm Insight is a product of Infinata, Inc., a Norwood, Mass.-based company that provides a suite of life sciences products including BioPharm Clinical(TM) and BioPharm Devices(TM).
Featuring an intuitive user interface, BioPharm Insight provides powerful searching capabilities, allowing the user to find precise and up-to-date information on full pipeline data, investigational and approved drug profiles, and licensing and M&A activity.
Through this relationship with BioPharm Insight, CHI will provide its member organizations a database of California-specific biopharma companies and their pipelines. CHI members will have access to BioPharm Insight through the CHI website (http://www.chi.org).
“This new partnership with BioPharm Insight adds tremendous value to our members,” said CHI President and CEO David Gollaher, Ph.D. “Access to this insider database is especially important to our emerging member companies.”
“Working with forward-looking organizations like CHI is something that we are very excited to be a part of,” said Ruth McHenry, Managing Director, Infinata. “Our team will work closely with CHI to ensure that their members are fully trained to use BioPharm Insight to their full advantage and to help create new business opportunities.”
About California Healthcare Institute
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org.
About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.
About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.
Infinata Media Contact: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131
CHI Media Contact: Erica Hiar, hiar[at]chi[dot]org, 202-974-6322